Cargando…

The ASXL1-G643Wvariant accelerates the development of CEBPA mutant acute myeloid leukemia

ASXL1 is one of the most commonly mutated genes in myeloid malignancies, including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In order to further our understanding of the role of ASXL1 lesions in malignant hematopoiesis, we generated a novel knockin mouse model carrying the mos...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Altri, Teresa, Wilhelmson, Anna S., Schuster, Mikkel B., Wenzel, Anne, Kalvisa, Adrija, Pundhir, Sachin, Hansen, Anne Meldgaard, Porse, Bo T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017816/ https://www.ncbi.nlm.nih.gov/pubmed/32381577 http://dx.doi.org/10.3324/haematol.2019.235150

Ejemplares similares

TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
por: Heyes, Elizabeth, et al.
Publicado: (2023)

Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
por: Jakobsen, Janus S., et al.
Publicado: (2019)

CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance
por: Wilhelmson, Anna S., et al.
Publicado: (2020)

H3K9 dimethylation safeguards cancer cells against activation of the interferon pathway
por: Hansen, Anne Meldgaard, et al.
Publicado: (2022)

The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
por: Ge, Ying, et al.
Publicado: (2019)

The impact of SWI/SNF and NuRD inactivation on gene expression is tightly coupled with levels of RNA polymerase II occupancy at promoters
por: Pundhir, Sachin, et al.
Publicado: (2023)

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Asada, Shuhei, et al.
Publicado: (2018)

Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
por: Adamo, Assunta, et al.
Publicado: (2022)

The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
por: Trempenau, Mette Louise, et al.
Publicado: (2023)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
por: Helbig, Grzegorz, et al.
Publicado: (2014)

Memorandum 643
por: CERN. Geneva. SPS-PS Experiments Committee
Publicado: (2000)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
por: Yuan, Ji, et al.
Publicado: (2023)

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2022)

ASXL1/2 mutations and myeloid malignancies
por: Medina, Edward A., et al.
Publicado: (2022)

Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia
por: Chen, Xinjie, et al.
Publicado: (2023)

Loss of Asxl2 leads to myeloid malignancies in mice
por: Li, Jianping, et al.
Publicado: (2017)

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
por: Pabst, T, et al.
Publicado: (2009)

Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia
por: Grossmann, V, et al.
Publicado: (2012)

Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
por: Xu, Xiaoyu, et al.
Publicado: (2021)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022)

In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis
por: Guo, Hong, et al.
Publicado: (2016)

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2012)

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
por: Hou, H-A, et al.
Publicado: (2009)

Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
por: Quintana-Bustamante, Oscar, et al.
Publicado: (2012)

From Laser Scanning to Finite Element Analysis of Complex Buildings by Using a Semi-Automatic Procedure
por: Castellazzi, Giovanni, et al.
Publicado: (2015)

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia
por: Schardt, Julian A, et al.
Publicado: (2010)

CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia
por: Hughes, James M, et al.
Publicado: (2014)

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations
por: Volpe, Giacomo, et al.
Publicado: (2019)

The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
por: Repele, Andrea, et al.
Publicado: (2019)

Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia
por: Schmidt, Luisa, et al.
Publicado: (2020)

Two Novel CEBPA Mutations in a Turkish Patient with Acute Myeloid Leukemia
por: Tokgun, PE, et al.
Publicado: (2021)

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
por: Wakita, Satoshi, et al.
Publicado: (2022)

Acute myeloid leukemia due to germline CEBPA mutation in a Syrian family
por: Wafa, Abdulsamad, et al.
Publicado: (2022)

Variable outcome and methylation status according to CEBPA mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatment
por: El-Sharkawi, Dima, et al.
Publicado: (2018)

SAT-643 Predictors of Technology Success in Cystic Fibrosis Related Diabetes
por: Jain, Ashna, et al.
Publicado: (2020)

Peak-valley-peak pattern of histone modifications delineates active regulatory elements and their directionality
por: Pundhir, Sachin, et al.
Publicado: (2016)

Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype
por: Kim, Sollip, et al.
Publicado: (2012)

In Silico Genetics Revealing 5 Mutations in CEBPA Gene Associated With Acute Myeloid Leukemia
por: Mustafa, Mujahed I, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_725f8j0vra443ed6art1bb4077